Health Invest Partners Ab Ligand Pharmaceuticals Inc Transaction History

Health Invest Partners Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$80.55 - $106.05 $1.63 Million - $2.14 Million	-20,200 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$128.36 - $147.04 $3.56 Million - $4.07 Million	-27,700 Reduced 57.83%	20,200 $2.77 Million
Q3 2017 Nov 13, 2017	SELL	$120.91 - $137.94 $1 Million - $1.14 Million	-8,300 Reduced 14.77%	47,900 $6.52 Million
Q2 2017 Aug 07, 2017	BUY	N/A	56,200	56,200 $6.82 Million

248

17.7M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

Stay updated on Health Invest Partners Ab with notifications on news.